Top Summary
The bill amends the SUPPORT for Patients and Communities Act by removing provisions related to model training programs for substance use disorder records, revising task force requirements for trauma-informed care, and updating stakeholder involvement and deadlines. It simplifies language in grant provisions, mandates reviews of drug scheduling and inclusion of all FDA-approved overdose reversal agents in HHS grants, and increases funding for recovery communities from $5 million to $17 million annually from 2026 to 2030.
Sub Summaries
- Amending the SUPPORT Act to Enhance Substance Use Disorder Training and Expand Trauma-Informed Care Task Force
- Simplification of Substance Use Disorder Treatment Grant Provisions in the SUPPORT Act
- Review and Rescheduling of Buprenorphine-Naloxone Products Under the Controlled Substances Act
- Ensuring Inclusive Coverage of Opioid Overdose Reversal Drugs in HHS Grant Programs
- empty title